Skip to content

Clinical trials

Phase 1/2 Carcinoma, Non-Small-Cell Lung trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 1/2 Country / region: Singapore Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20092
20132
20141
20153
20173
20193
20201
20212
20221
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting7
Completed6
Active, not recruiting5
Terminated3
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Hoffmann-La Roche3
National University Hospital, Singapore2
AVEO Pharmaceuticals, Inc.1
Bayer1
BlossomHill Therapeutics1
Cullinan Therapeutics Inc.1
Eli Lilly and Company1
Hummingbird Bioscience1
Inhibrx Biosciences, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung23
Lung Neoplasms7
Head and Neck Neoplasms5
Neoplasms5
Neoplasms by Site5
Carcinoma4
Colorectal Neoplasms4
Lung Diseases4
Melanoma4
Neoplasms by Histologic Type4

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.